← All trials
NCT04870502
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Apr 1, 2019
- Primary completion
- Jul 31, 2020
- Completion date
- Jul 31, 2020
- First posted
- May 3, 2021
- Last posted
- May 3, 2021
- Enrollment
- 161
- Arms / groups
- 2 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Saudi German Hospital - MadinahLead sponsor
- Saudi German Hospital - MadinahReponsible party - principal investigator
- Saudi German Hospital - MadinahOverall official - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.